Medicine News and Research

RSS

Scientists embark on a five-year study of the effects of soy isoflavones found in dietary supplements on various body tissues

A multidisciplinary team of scientists at the University of Illinois at Urbana-Champaign is embarking on a comprehensive five-year study of the effects of soy isoflavones found in dietary supplements on various body tissues.

29 Sep 2004

Black men in the United States are significantly less likely to be screened for prostate cancer

Although black men in the United States are more likely than white men to be diagnosed with advanced prostate cancer and have a two-fold greater risk of dying from it, they are significantly less likely to be screened for prostate cancer

29 Sep 2004

Researchers have identified the mechanism by which marijuana may affect learning and memory

Marijuana use has long been known to cause problems with learning and memory. Now, researchers at the Albert Einstein College of Medicine of Yeshiva University have identified the mechanism by which marijuana may affect activity in the hippocampus

29 Sep 2004

Women aged 16 to 19 are 43% more likely to test positive for Chlamydia than women in their early twenties

Women aged 16 to 19 are 43% more likely to test positive for Chlamydia than women in their early twenties, show data from the first year of the Chlamydia screening programme in England, reported in Sexually Transmitted Infections.

29 Sep 2004

Bacterium Haemophilus influenza has to secrete a glue-like protein

To stick to cells in the respiratory tract and start an infection, the bacterium Haemophilus influenza has to secrete a glue-like protein. Researchers at Washington University School of Medicine in St. Louis report this week that a study of the valve that lets out the glue has produced some surprising information.

29 Sep 2004

IBM and Cleveland Clinic to develop a translational medicine platform to support genetic research

IBM and The Cleveland Clinic today announced an agreement to develop a translational medicine platform at The Cleveland Clinic that will use information from electronic medical records to support basic and genetic research.

29 Sep 2004

ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine

ID Biomedical announced today that it has been awarded a US$9.5 million grant from the U.S. National Institutes of Health (NIH) to develop its cell culture-based influenza vaccine.

29 Sep 2004

Studies confirm that chronic kidney disease independently increases the risk of developing cardiovascular disease

A pair of new epidemiology studies confirms that chronic kidney disease independently increases the risk of developing cardiovascular disease, even among people with early kidney disease and after considering other risk factors such as diabetes, hypertension and high cholesterol.

29 Sep 2004

Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes

About 40 percent of adults ages 40 to 74 - or 41 million people - have pre-diabetes, a condition that raises a person’s risk for developing type 2 diabetes, heart disease, and stroke.

29 Sep 2004

Secure web sites can improve communications about critically ill patients for hometown physicians and loved ones

Password-protected Web sites can improve communications about critically ill patients for hometown physicians and loved ones, according to a study by researchers at Doernbecher Children's Hospital.

29 Sep 2004

Research confirms benefits of commonly used traditional remedies for a range of illnesses

Research presented to the British Pharmaceutical Conference today, confirms the benefits of commonly used traditional remedies for a range of illnesses, including cancer, offering a scientific justification for their use.

29 Sep 2004

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Scientists at the University of Aberdeen have been awarded £196,166 to help fund pioneering research, which is exploring a method of combating certain conditions and diseases such as asthma and multiple sclerosis.

29 Sep 2004

Complete laparoscopic skills training curriculum based entirely in the laboratory

A pilot in training doesn’t fly a plane at his first lesson. And so it goes for surgeons in training. To learn such complex skills, it’s safer and more effective to practice first on a simulator.

29 Sep 2004

Should medical knowledge be extended to enhance the lives of those who are already healthy?

This question and others are addressed in three articles about cosmetic neurology in the September 28 issue of Neurology, the scientific journal of the American Academy of Neurology.

28 Sep 2004

Clusters of genes within human aortas appear to predict risk for atherosclerosis

Duke University Medical Center researchers have identified specific clusters of genes within human aortas that appear to predict with great specificity which patients may be at highest risk for developing atherosclerosis, as well as the severity of the disease.

28 Sep 2004

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Phase II trials of the first second-generation antisense cancer drug to be used in patients are soon to be underway in the wake of a successful Phase I study, which has demonstrated that the new drug blocks its target gene in exactly the way it is designed to do.

28 Sep 2004

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

Arsenic trioxide – a highly poisonous substance best known as an effective weed killer or pesticide and notorious for being a favourite ‘weapon’ of choice in murder mystery novels, is being re-invented as a treatment for a rare type of leukaemia.

28 Sep 2004

DuPont CEO says consumers will increasingly depend on biotechnology

DuPont Chairman and Chief Executive Officer Charles O. Holliday, Jr. today said significant progress has been made in demonstrating the benefits of biotechnology, in its acceptance, and in the advancement of new and exciting products the technology is making possible.

28 Sep 2004

Half of Britons at risk from heart disease

More than half the people tested in a national pharmacy initiative to identify the threat of high blood pressure were found to be at risk according to new research launched today at the British Pharmaceutical Conference.

27 Sep 2004

Active ingredients of soya may help beat breast cancer

Researchers are investigating whether it is possible to turn the active ingredients of soya into a useful medicine that may help to beat breast cancer, the British Pharmaceutical Conference heard today.

27 Sep 2004

Medicine News and Research

Scientists embark on a five-year study of the effects of soy isoflavones found in dietary supplements on various body tissues

Black men in the United States are significantly less likely to be screened for prostate cancer

Researchers have identified the mechanism by which marijuana may affect learning and memory

Women aged 16 to 19 are 43% more likely to test positive for Chlamydia than women in their early twenties

Bacterium Haemophilus influenza has to secrete a glue-like protein

IBM and Cleveland Clinic to develop a translational medicine platform to support genetic research

ID Biomedical awarded US$9.5 million to develop its cell culture-based influenza vaccine

Studies confirm that chronic kidney disease independently increases the risk of developing cardiovascular disease

Millions of Asian Americans and Pacific Islanders at increased risk for type 2 diabetes

Secure web sites can improve communications about critically ill patients for hometown physicians and loved ones

Research confirms benefits of commonly used traditional remedies for a range of illnesses

New funding for Scottish scientists to tackle diseases such as asthma and multiple sclerosis

Complete laparoscopic skills training curriculum based entirely in the laboratory

Should medical knowledge be extended to enhance the lives of those who are already healthy?

Clusters of genes within human aortas appear to predict risk for atherosclerosis

Phase II trials of the first second-generation antisense cancer drug to be used in patients soon to be underway

Arsenic trioxide - invented as a treatment for a rare type of leukaemia

DuPont CEO says consumers will increasingly depend on biotechnology

Half of Britons at risk from heart disease

Active ingredients of soya may help beat breast cancer

Everything there is to know about biosimilars eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News